AEPCX
Price
$61.92
Change
+$0.71 (+1.16%)
Updated
Aug 21 closing price
Net Assets
137.41B
FCPIX
Price
$38.85
Change
+$0.12 (+0.31%)
Updated
Aug 20 closing price
Net Assets
18.02B
Interact to see
Advertisement

AEPCX vs FCPIX

AEPCX vs FCPIX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. FCPIX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a StrongBuy and FCPIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 137B vs. FCPIX (18B). AEPCX pays higher dividends than FCPIX: AEPCX (2.13) vs FCPIX (0.52). AEPCX was incepted earlier than FCPIX: AEPCX (25 years) vs FCPIX (29 years). AEPCX (1.58) is less costly to investors than FCPIX (0.89). FCPIX is a more actively managed with annual turnover of: 96.00 vs. AEPCX (50.00). FCPIX has a lower initial minimum investment than AEPCX: FCPIX (0) vs AEPCX (250). AEPCX annual gain was more profitable for investors over the last year : 7.17 vs. FCPIX (3.84). FCPIX return over 5 years is better than : 22.75 vs. AEPCX (-3.27).
AEPCXFCPIXAEPCX / FCPIX
Total Expense Ratio1.580.89178%
Annual Report Gross Expense Ratio1.580.89178%
Fund Existence25 years29 years-
Gain YTD7.1848.21787%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets137B18B761%
Annual Yield % from dividends2.130.52411%
Returns for 1 year7.173.84187%
Returns for 3 years26.1048.2354%
Returns for 5 years-3.2722.75-14%
Returns for 10 years40.04131.1231%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSEDX21.640.15
+0.70%
Columbia Intrinsic Value Institutional 2
ADCYX24.870.15
+0.61%
American Century Disciplined Growth Y
MFECX112.680.63
+0.56%
MFS Growth C
BAUAX31.760.15
+0.47%
Brown Advisory Small-Cap Fdmtl Val Adv
APFDX21.160.09
+0.43%
Artisan Global Discovery Investor